These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31659641)

  • 1. ASO Author Reflections: Circulating Tumor Cell Count is a Prognostic Factor in Patients with Resected Colorectal Cancer Liver Metastases.
    Arrazubi V
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):842. PubMed ID: 31659641
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial.
    Arrazubi V; Mata E; Antelo ML; Tarifa A; Herrera J; Zazpe C; Teijeira L; Viudez A; Suárez J; Hernández I; Vera R
    Ann Surg Oncol; 2019 Sep; 26(9):2805-2811. PubMed ID: 31209673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases.
    Rahbari NN; Reissfelder C; Mühlbayer M; Weidmann K; Kahlert C; Büchler MW; Weitz J; Koch M
    Ann Surg Oncol; 2011 Aug; 18(8):2182-91. PubMed ID: 21598056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique localization of circulating tumor cells in patients with hepatic metastases.
    Jiao LR; Apostolopoulos C; Jacob J; Szydlo R; Johnson N; Tsim N; Habib NA; Coombes RC; Stebbing J
    J Clin Oncol; 2009 Dec; 27(36):6160-5. PubMed ID: 19884529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
    Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
    Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis.
    Katsuno H; Zacharakis E; Aziz O; Rao C; Deeba S; Paraskeva P; Ziprin P; Athanasiou T; Darzi A
    Ann Surg Oncol; 2008 Nov; 15(11):3083-91. PubMed ID: 18787906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASO Author Reflections: Colorectal Liver Metastases Early Progression After Chemotherapy: A Possible Contraindication to Surgery?
    Torzilli G; Viganò L
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):525-526. PubMed ID: 30511094
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating angiogenic factors, tumor cells, and outcome after resection of metastatic colorectal cancer--what does it mean?
    Parikh AA; Ellis LM
    Ann Surg Oncol; 2011 Aug; 18(8):2111-3. PubMed ID: 21626082
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis.
    Søreide K; Watson MM; Lea D; Nordgård O; Søreide JA; Hagland HR;
    J Transl Med; 2016 Jun; 14(1):192. PubMed ID: 27357108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter to the editor: a meta-analysis of preoperative circulating and disseminated tumor cells are negative predictors of survival in patients undergoing hepatic resection of colorectal liver metastases.
    Ma B; Wang L; Gao P; Song Y; Wang Z
    Int J Colorectal Dis; 2016 Aug; 31(8):1523-4. PubMed ID: 26951177
    [No Abstract]   [Full Text] [Related]  

  • 11. Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases.
    Connor AA; McNamara K; Al-Sukhni E; Diskin J; Chan D; Ash C; Lowes LE; Allan AL; Zogopoulos G; Moulton CA; Gallinger S
    Ann Surg Oncol; 2016 Jul; 23(7):2168-75. PubMed ID: 26714949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.
    Hinz S; Bockhorst J; Röder C; Egberts JH; Schafmayer C; Küchler T; Becker T; Kalthoff H
    Ann Surg Oncol; 2012 Aug; 19(8):2539-46. PubMed ID: 22395998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of circulating tumor cells in colorectal cancer liver metastasis patients before and after cryosurgery.
    Shi J; Li Y; Liang S; Zeng J; Liu G; Mu F; Li H; Chen J; Liu T; Niu L
    Cancer Biol Ther; 2016 Sep; 17(9):935-42. PubMed ID: 27415969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASO Author Reflections: Patients with Recurrence Amenable to Local Therapy for Colorectal Liver Metastases May Experience Improved Survival.
    Boyev A; Newhook TE
    Ann Surg Oncol; 2024 Apr; 31(4):2600-2601. PubMed ID: 38326638
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prognostic factors of colorectal cancer patients with synchronous liver metastasis treated with simultaneous liver and colorectal resection].
    Wang Z; Zhou ZX; Liang JW; Bai XF; Bi JJ
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):372-5. PubMed ID: 18953839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells and sample size: the more, the better.
    Lalmahomed ZS; Kraan J; Gratama JW; Mostert B; Sleijfer S; Verhoef C
    J Clin Oncol; 2010 Jun; 28(17):e288-9; author reply e290. PubMed ID: 20439640
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of disseminated tumor cells in liver biopsies of colorectal cancer patients is not associated with a worse prognosis.
    Koch M; Kienle P; Logan E; Antolovic D; Galindo L; Schmitz-Winnenthal FH; Schmidt J; Herfarth C; Weitz J
    Ann Surg Oncol; 2007 Feb; 14(2):810-7. PubMed ID: 17103077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of circulating endothelial cells in metastatic colorectal cancer.
    Rahbari NN; Schölch S; Bork U; Kahlert C; Schneider M; Rahbari M; Büchler MW; Weitz J; Reissfelder C
    Oncotarget; 2017 Jun; 8(23):37491-37501. PubMed ID: 28415583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASO Author Reflections: Prognostic Impact of Budding Grade on Patients with Residual Liver Recurrence of Colorectal Cancer After Initial Hepatectomy.
    Noro T
    Ann Surg Oncol; 2020 Dec; 27(13):5208. PubMed ID: 32770295
    [No Abstract]   [Full Text] [Related]  

  • 20. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.
    Barbazán J; Muinelo-Romay L; Vieito M; Candamio S; Díaz-López A; Cano A; Gómez-Tato A; Casares de Cal Mde L; Abal M; López-López R
    Int J Cancer; 2014 Dec; 135(11):2633-43. PubMed ID: 24752533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.